NCT00654381 - Japanese P III vs Voglibose and Placebo | Biotech Hunter

Enrollment

561

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

BI 1356

5 mg/daily

DRUG

BI 1356

10 mg/daily

DRUG

voglibose placebo

three times daily

DRUG

BI 1356 placebo

once daily

DRUG

voglibose

0.6 mg/daily

Trial Locations (47)

Unknown

1218.23.05 Boehringer Ingelheim Investigational Site, Asahi, Chiba

1218.23.06 Boehringer Ingelheim Investigational Site, Funabashi, Chiba

1218.23.21 Boehringer Ingelheim Investigational Site, Hitachinaka, Ibaraki

1218.23.44 Boehringer Ingelheim Investigational Site, Hitachiota, Ibaraki

1218.23.09 Boehringer Ingelheim Investigational Site, Imizu, Toyama

1218.23.45 Boehringer Ingelheim Investigational Site, Inashiki-gun, Ibaraki

1218.23.13 Boehringer Ingelheim Investigational Site, Izumisano, Osaka

1218.23.27 Boehringer Ingelheim Investigational Site, Kariya, Aichi

1218.23.47 Boehringer Ingelheim Investigational Site, Kitakatsushika-gun, Saitama

1218.23.39 Boehringer Ingelheim Investigational Site, Kitakyuushuu, Fukuoka

1218.23.02 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1218.23.03 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1218.23.10 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

1218.23.37 Boehringer Ingelheim Investigational Site, Marugame, Kagawa

1218.23.38 Boehringer Ingelheim Investigational Site, Marugame, Kagawa

1218.23.23 Boehringer Ingelheim Investigational Site, Matsumoto, Nagano

1218.23.07 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo

1218.23.25 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.23.26 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.23.28 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.23.29 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.23.30 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.23.04 Boehringer Ingelheim Investigational Site, Naka, Ibaraki

1218.23.15 Boehringer Ingelheim Investigational Site, Nishi-ku, Hiroshima, Hiroshima

1218.23.34 Boehringer Ingelheim Investigational Site, Nishi-ku, Sakai, Osaka

1218.23.22 Boehringer Ingelheim Investigational Site, Nishishinjyuku, Shinjyuku-ku, Tokyo

1218.23.16 Boehringer Ingelheim Investigational Site, Oita, Oita

1218.23.40 Boehringer Ingelheim Investigational Site, Oita, Oita

1218.23.36 Boehringer Ingelheim Investigational Site, Okayama, Okayama

1218.23.11 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.23.12 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.23.32 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.23.33 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.23.35 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.23.17 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.18 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.19 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.41 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.42 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.43 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1218.23.01 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1218.23.20 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1218.23.46 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1218.23.08 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo

1218.23.14 Boehringer Ingelheim Investigational Site, Suita, Osaka

1218.23.31 Boehringer Ingelheim Investigational Site, Takatsuki, Osaka

1218.23.48 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa